T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy.

Heijink, D M; Kater, A P; Hazenberg, M D; Hagenbeek, A; Kersten, M J

Heijink, D M; Kater, A P; Hazenberg, M D; Hagenbeek, A; Kersten, M J.

Affiliation

Heijink DM; Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands.

Neth J Med ; 74(4): 147-51, 2016 May.

Article in En | MEDLINE | ID: mdl-27185772

Subject(s)

Lymphoproliferative Disorders/therapy; Receptors, Antigen, T-Cell/therapeutic use; B-Lymphocytes; Clinical Trials as Topic; Humans; Receptors, Antigen, T-Cell/administration & dosage; Receptors, Antigen, T-Cell/immunology; T-Lymphocytes

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Lymphoproliferative Disorders Limits: Humans Language: En Journal: Neth J Med Year: 2016 Document type: Article

Search on Google

XML

PubMed Links